New Blood Test Paves the Way for More Effective Ovarian Cancer Treatments
Every year, more than 300,000 women worldwide receive the devastating diagnosis of ovarian cancer, a disease notorious for its complexity ...
Tag: PARP inhibitors
Optimized Tumor Therapy: Phase I Trial of Gapped Scheduling
In a groundbreaking development that could redefine cancer therapy, researchers have unveiled a novel approach to delivering topoisomerase I (top1) ...
Ovarian cancer discovery: targetable variant RAD51D found in Chinese patients
Researchers from BGI Genomics and Fudan University published new findings on OV among Chinese patients in JCO Global Oncology. The ...
POPULAR NEWS
-
New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom
-
Scientists Uncover Chameleon’s Telephone-Cord-Like Optic Nerves, A Feature Missed by Aristotle and Newton
-
ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy
-
Neurological Impacts of COVID and MIS-C in Children